Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Adrian Olszewski"'
Publikováno v:
Biotechnology & Biotechnological Equipment, Vol 38, Iss 1 (2024)
Bulgarian real-world data on denosumab use for the prevention of skeletal-related events (SREs) associated with bone metastases (BM) from prostate cancer (PC) are lacking. This observational study enrolled 100 adult PC patients with ≥1 BM receiving
Externí odkaz:
https://doaj.org/article/61c41b94e4a24cd19e4478785e911fdf
Autor:
Adrian Olszewski, Kinga Wzgarda-Raj
Publikováno v:
IUCrData, Vol 6, Iss 10, p x211102 (2021)
The title compound, C4H4N2S, was obtained by the reduction of 2-mercaptopyrazine (during its crystallization with 2-mercaptopyrazine and isonicotinic acid N-oxide in ethanol solution. It crystallizes in the monoclinic space group P21/m. In the crysta
Externí odkaz:
https://doaj.org/article/53a1a50263074d148981f47a4e55920c
Autor:
Adrian, Olszewski, Kinga, Wzgarda-Raj
Publikováno v:
IUCrData. 6(Pt 10)
The title compound, C
Autor:
Atanaska Elenkova, Ralitsa Robeva, Tsvetalina Tankova, Roumyana Dimova, Anna-Maria Borissova, Adrian Olszewski, Vasil I. Lachev, Reneta Petkova
Publikováno v:
Diabetes Therapy
Introduction Patients with diabetes and familial hypercholesterolaemia (FH) are at very high risk of cardiovascular events, but rates of FH detection are very low in most countries, including Bulgaria. Given the lack of relevant data in the literatur